Breaking News
Too Close for Comfort? Washington Judge's AGO Ties Spark Recusal
Keynesian Economics meme...
Blast Them: A Rutgers Scientist Uses Lasers to Kill Weeds
Christian Faith-Based Groups Helped Rebuild North Carolina After Hurricane Helene Destruction
Top Tech News
New Spray-on Powder Instantly Seals Life-Threatening Wounds in Battle or During Disasters
AI-enhanced stethoscope excels at listening to our hearts
Flame-treated sunscreen keeps the zinc but cuts the smeary white look
Display hub adds three more screens powered through single USB port
We Finally Know How Fast The Tesla Semi Will Charge: Very, Very Fast
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.